Adial Pharmaceuticals rebrands as Azora Therapeutics, ticker AZR
Alpha Vantage · StreetInsider · · AI-summarised by FinFlash
Adial Pharmaceuticals has rebranded as Azora Therapeutics, Inc., with its common stock trading under the ticker "AZR" on the Nasdaq Capital Market starting October 29, 2026. The change follows stockholder approval to convert Series A preferred stock and exercise prefunded warrants tied to its June 2026 Azora acquisition.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.